Schibsted ASA/ NO0010736879 /
07.05.2024 15:26:27 | Изменение +24.70 | Объем сделки | Бид30.04.2024 | Предложение30.04.2024 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
326.30NOK | +8.19% | 397 Оборот: 129,541.10 |
-Величина цены спроса: - | -Величина цены предложения: - | 74.05 млрдNOK | 0.61% | 4.42 |
GlobeNewswire
22:05
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-...
GlobeNewswire
22:05
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
22:05
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
22:05
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
GlobeNewswire
22:05
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
22:05
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
22:05
Inuvo Reports 44% Year-Over-Year Revenue Growth to $17.0 Million for the First Quarter of 2024
GlobeNewswire
22:05
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2024
GlobeNewswire
22:05
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
GlobeNewswire
22:05
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Yea...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница